Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 15, 2022 - Issue
Submit an article Journal homepage
171
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Long-Term Efficacy and Clinical Remission After Benralizumab Treatment in Patients with Severe Eosinophilic Asthma: A Retrospective Study

Takanori NumataDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2784-2331View further author information
ORCID Icon,
Jun ArayaDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, JapanView further author information
,
Keitaro OkudaDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, JapanView further author information
,
Hanae MiyagawaDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-0527-4882View further author information
ORCID Icon,
Shunsuke MinagawaDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, JapanView further author information
,
Takeo IshikawaDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, JapanView further author information
,
Hiromichi HaraDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, JapanView further author information
&
Kazuyoshi KuwanoDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-3729-1716View further author information
ORCID Icon show all
Pages 1731-1741 | Received 30 Sep 2022, Accepted 23 Nov 2022, Published online: 29 Nov 2022

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Andriana I Papaioannou, Evangelia Fouka, Konstantinos Bartziokas, Maria Kallieri, Angelos Vontetsianos, Konstantinos Porpodis, Nikoletta Rovina, Stelios Loukides & Petros Bakakos. (2023) Defining response to therapy with biologics in severe asthma: from global evaluation to super response and remission. Expert Review of Respiratory Medicine 17:6, pages 481-493.
Read now

Articles from other publishers (5)

Andrea Portacci, Ilaria Iorillo, Vitaliano Nicola Quaranta, Leonardo Maselli, Ernesto Lulaj, Enrico Buonamico, Silvano Dragonieri & Giovanna Elisiana Carpagnano. (2023) Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience. Respiratory Medicine 217, pages 107348.
Crossref
Adrien Cottu, Matthieu Groh, Charlene Desaintjean, Sylvain Marchand-Adam, Loïc Guillevin, Xavier Puechal, Stacy Beaumesnil, Estibaliz Lazaro, Maxime Samson, Camille Taille, Cécile-Audrey Durel, Elizabeth Diot, Sarah Nicolas, Laurent Guilleminault, Mikael Ebbo, Pascal Cathebras, Clairelyne Dupin, Halil Yildiz, Nabil Belfeki, Grégory Pugnet, Pierre Chauvin, Stephane Jouneau, Francois Lifermann, Jean-Philippe Martellosio, Vincent Cottin & Benjamin Terrier. (2023) Benralizumab for eosinophilic granulomatosis with polyangiitis. Annals of the Rheumatic Diseases, pages ard-2023-224624.
Crossref
Bruno Sposato, Francesco Bianchi, Alberto Ricci & Marco Scalese. (2023) Clinical Asthma Remission Obtained with Biologics in Real Life: Patients’ Prevalence and Characteristics. Journal of Personalized Medicine 13:6, pages 1020.
Crossref
Alessandra Vultaggio, Maria Aliani, Elena Altieri, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Paolo Cameli, Giorgio Walter Canonica, Cristiano Caruso, Stefano Centanni, Maria D’Amato, Fausto De Michele, Stefano Del Giacco, Fabiano Di Marco, Francesco Menzella, Girolamo Pelaia, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Gianenrico Senna, Marco Benci, Silvia Boarino & Jan Walter Schroeder. (2023) Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study. Respiratory Research 24:1.
Crossref
Angelantonio Maglio, Carolina Vitale, Corrado Pelaia, Maria D’Amato, Luigi Ciampo, Eliana Sferra, Antonio Molino, Giulia Pelaia & Alessandro Vatrella. (2023) Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study. International Journal of Molecular Sciences 24:3, pages 2455.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.